Age | Tumor type | NS | Mitotic count/10 HPF | TN | HER2/ER | Miller-Payne grade | Tumor size (MRI/PET) | Tumor size (US) | Treatment regimen |
---|---|---|---|---|---|---|---|---|---|
59 | IDC | 6 | 2 | – | −/+ | 3 | 2.7 | 1.7 | ACT |
55 | ILC | 6 | 1 | – | −/+ | 4 | 8.6 | –a | ACT |
33 | IDC | 4 | 2 | – | −/+ | 3 | 1.6 | 1.5 | ACT |
61 | IDC/ILC | 6 | 1 | + | −/− | 1 | 3.3 | 1.9 | ACT |
59 | IDC | 6 | 5 | – | −/+ | 2 | 5.6 | 2.2 | ACT |
68 | IDC | 6 | 3 | – | −/+ | 3 | 7.6 | 2.2 | ACT |
51 | IDC | 9 | 40 | + | −/− | 5 | 3.6 | 2.2 | ACT |
53 | IDC | 9 | 62 | + | −/− | 3 | PET: 3.7 | 4.3 | ACT |
 |  |  |  |  |  |  |  |  | TPT |
51 | IDC | 7 | 15 | – | +/+ | 5 | N/A | 1.2 | TPT |
74 | IDC | 8 | 8 | – | +/− | 5 | 6.2 | –a | TPT |
57 | IDC | 9 | 16 | – | +/− | 4 | 6.9 | –b | TPT&FEC |
 |  |  |  |  |  |  |  |  | TPT |
51 | IDC | 9 | 14 | – | +/− | 5 | 3.0 | 1.9 | TPT |
59 | IDC | 7 | 1 | – | +/+ | 5 | N/A | 0.6 | TPT |
61 | IDC | 4 | 3 | – | +/+c | 5 | 2.0 | 1.4 | TPT |
37 | IDC/ILC | 8 | 9 | – | +/+ | 4 | 3.6 | 1.9 | TPT |
54 | IDC | 8 | 20 | – | +/+ | 5 | 2.9 | 2.3 | TPT |
40 | IDC | 8 | 15 | – | +/+ | 5 | 2.2 | 2.1 | TPT |
62 | IDC | 9 | 12 | – | +/+ | 3 | PET: 1.8 | 1.2 | TPT |
37 | IDC | 8 | 42 | – | +/+c | 5 | 1.5 | 1.6 | TPT |
72 | IDC | 9 | 42 | – | −/+ | 3 | 4.3 | 2.3 | TC |
57 | IDC | 9 | 14 | + | −/− | 5 | 2.3 | 1.3 | Carbo/T |
41 | IDC | 9 | 8 | + | −/− | 3 | 4.0 | 4.0 | Carbo/T |